Pay in 4 interest-free payments of $5.28 Learn more
Ships within 48 hours · Estimated delivery Sep 17 - Sep 22
dual glp 1 glucagon receptor agonists Incretin-based therapies in MASLD/MASH: from GLP-1 to and triple agonists Emerging Role of Dual b3 Count:30
Emerging Role of Dual GLP-1 and GIP Receptor Agonists | DMSO | Dove Medical Press
Int J Mol Sci (2013) 14(11):21513–24
b3
Count:30
Lancet 2018;391:2607–18.ArticlePubMed 46
US$ 29.94
US$ 20.60
US$ 21.72
US$ 28.64
US$ 29.47
US$ 20.33
US$ 22.90
US$ 25.67
US$ 28.89
US$ 20.30
US$ 25.14
